OPRM1 and Respiratory insufficiency due to muscle weakness: The pharmacological profile of mitragynine, particularly its partial agonism at mu-opioid receptors and interactions with serotonin and dopamine receptors, suggests an analgesic effect with potentially fewer side effects—such as reduced risk of respiratory depression and dependence—compared to conventional opioids.